Third-quarter financial reports from several industry leaders hint that a recovery of the $11 billion market for hip and knee replacements is under way, according to a report from Dow Jones Newswires.
Sales of devices slowed earlier this year because many elective hip and knee procedures were being postponed in the face of lost insurance coverage, high out-of-pocket charges or inability to take time off from work.
However, recent quarterly reports from Zimmer Holdings, Stryker Corp. and Johnson & Johnson have shown a modest improvement in sales.
Read Dow Jones Newswires’ report on the joint replacement market.
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.